malaria

Dear Research Advocate: Yesterday, President Obama tweeted about the effects of sequestration on medical research. From @barackobama, “The #sequester is slowing the pace of medical research, delaying the discovery of cures and treatments. Read more .” It is terrific that the president is helping drive increased attention to medical research. Our thanks to him and also to all who have joined our Memorial Day recess week of social media advocacy . The American Heart Association posted this great image to its Facebook page; we also thank Society for Neuroscience , BIO , The Endocrine Society , Melanoma Research Alliance , University of Maryland School of Medicine , CURE Epilepsy and UPenn...
by Morgan McCloskey, Global Health Intern and Ellie Dehoney, Vice President of Policy and Programs at Research!America. This entry was originally posted as a guest contribution to the USAID IMPACT Blog. Doctor prepares malaria treatment. Photo credit: IMAD In the past decade, U.S. investments in science, technology and innovation have led to critical breakthroughs in prevention, diagnosis and treatment of deadly global diseases. We now have a meningitis vaccine for African populations, a new test that can quickly diagnose drug-resistant TB and promising data indicating that a vaccine could prevent HIV infection. We have developed desperately needed new drugs for neglected diseases and have...
April 25 is World Malaria Day , and this year’€™s theme is ’€œInvest in the Future: Defeat Malaria.’€ More than half of the world’€™s population is at risk for malaria, a potentially fatal disease that is transmitted through mosquitoes. Strong investments in malaria research and programming have helped reduce global malaria mortality rates by 26% since 2000, and 50 countries are on track to reduce malaria cases by 75% by 2015 . World Malaria Day is an opportunity to celebrate these successes and raise awareness of the investments that are still needed to fight this life-threatening disease. Despite the hard-won progress made against malaria, approximately 660,000 people die from this...
An endeavor twelve years in the making, University of California, Berkeley researchers are celebrating a breakthrough in synthetic biology and malaria treatment. A research team led by chemical engineer Jay Keasling began with a straightforward’€”though not easy’€”goal of genetically reprogramming a simple single celled organism, yeast, so that it would produce a chemical compound normally only found in the sweet wormwood plant. This compound is the starting material for one of the most effective anti-malaria medications available on the market. Yet, because the compound was derived from a plant that grows in select areas around the world, the availability and price were inconsistent...
On December 3, Policy Cures released its fifth annual G-FINDER report , a comprehensive survey of funding for research and development for neglected diseases. The report tracks global public, private and philanthropic investments into R&D for 31 diseases, including HIV/AIDS, tuberculosis, malaria and NTDs. In positive news, this year’€™s report shows that total funding has actually increased by $443 million since 2007. The report demonstrates that government funding, which accounts for over two-thirds of all investment, is increasingly going toward basic academic research, rather than product development. Research!America believes it is vital that the entire research pipeline be fully...
On September 21 st , Senator Chris Coons (D-DE) and Roger Wicker (R-MS) announced that the Senate Malaria Working Group was turning into an official Senate congressional caucus focused on combating 17 neglected tropical diseases (NTDs) in addition to malaria. With NTDs affecting over 1.4 billion people worldwide and documented cases of NTDs here in the U.S., this commitment to finding new solutions is good news. Past U.S. government involvement in the fight against NTDs has yielded promising results. The National Institutes of Health and the Department of Defense have funded crucial basic research for NTDs. Similarly, the Centers for Disease Control and Prevention have implemented strong...
A graphic from a recent amfAR report shows the potential loss of life because of across-the-board cuts, or sequestration. Research!America’s report on sequestration detailed the devastating impact that the sequester, or across-the-board cuts that are scheduled to take place in 2013, will have on federally funded research to improve health. Now, a recent report by amfAR trains the focus of sequestration on global health. Just as we found, amfAR reaches the same conclusion: Sequestration isn’t worth the cost. The cuts would save $689 million ’€” or 0.63% of the required deficit reduction for FY13. And at what cost? HIV/AIDS treatment for 273,000 fewer people, potentially leading to 62,000...

Sidebar Quote

You can change the image of things to come. But you can’t do it sitting on your hands … The science community should reach out to Congress and build bridges.
The Honorable John E. Porter